Zevra Therapeutics Inc (ZVRA)
6.92
-0.39
(-5.34%)
USD |
NASDAQ |
Sep 27, 16:00
6.92
0.00 (0.00%)
After-Hours: 20:00
Zevra Therapeutics Net Income (Annual): -46.05M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
December 31, 2023 | -46.05M |
December 31, 2022 | -26.77M |
December 31, 2021 | -8.555M |
December 31, 2020 | -12.76M |
December 31, 2019 | -24.52M |
December 31, 2018 | -56.47M |
Date | Value |
---|---|
December 31, 2017 | -43.39M |
December 31, 2016 | -16.52M |
December 31, 2015 | -54.66M |
December 31, 2014 | -24.46M |
December 31, 2013 | -5.226M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-46.05M
Minimum
2023
-8.555M
Maximum
2021
-23.73M
Average
-24.52M
Median
2019
Net Income (Annual) Benchmarks
Vanda Pharmaceuticals Inc | 2.509M |
BioCardia Inc | -11.57M |
Verrica Pharmaceuticals Inc | -67.00M |
Xeris Biopharma Holdings Inc | -62.26M |
Crinetics Pharmaceuticals Inc | -214.53M |